5 Results for "

PWT

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "PWT" in MCE Product Catalog:

Cat. No.: HY-109198
CAS No.: 1401436-95-0
Purity:  99.90%
Synonyms: ME-401; PWT-143
Target:  

PI3K Akt

Research Areas:  

Cancer

Zandelisib (ME-401) is a selective, orally active, non-covalent inhibitor of PI3Kδ. Zandelisib can sustainably inhibit AKT phosphorylation and downstream signaling pathways. Zandelisib can be used in the study of malignancies such as relapsed/refractory B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-15960A
CAS No.: 1246203-36-0
Synonyms: VDC-597; SN33597
Target:  

PI3K mTOR Apoptosis

Research Areas:  

Cancer

PWT-33597 (VDC-597) is a dual inhibitor of PI3Kα and mTOR, which can effectively block the signaling downstream of PI3K and mTOR. PWT-33597 is capable of inducing tumor cell apoptosis and inhibiting tumor growth. PWT-33597 has anti-tumor activity and can be used in the research of tumors such as renal cell carcinoma .
loading...
    loading...
Cat. No.: HY-15960
CAS No.: 1246203-32-6
Synonyms: VDC-597 free base
Target:  

PI3K mTOR Apoptosis

Research Areas:  

Cancer

PWT-33597 (VDC-597) free base is a dual inhibitor of PI3Kα and mTOR, which can effectively block the signaling downstream of PI3K and mTOR. PWT-33597 free base is capable of inducing tumor cell apoptosis and inhibiting tumor growth. PWT-33597 free base has anti-tumor activity and can be used in the research of tumors such as renal cell carcinoma .
loading...
    loading...
Cat. No.: HY-109198A
CAS No.: 2839515-65-8
Synonyms: ME-401 hydrochloride; PWT-143 hydrochloride
Target:  

PI3K Akt

Research Areas:  

Cancer

Zandelisib (ME-401) hydrochloride is a selective, orally active, non-covalent inhibitor of PI3Kδ. Zandelisib hydrochloride can sustainably inhibit AKT phosphorylation and downstream signaling pathways. Zandelisib hydrochloride can be used in the study of malignancies such as relapsed/refractory B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-109198R
CAS No.: 1401436-95-0
Synonyms: ME-401 (Standard); PWT-143 (Standard)
Research Areas:  

Cancer

Zandelisib (Standard) is the analytical standard of Zandelisib (HY-109198). This product is intended for research and analytical applications. Zandelisib (ME-401) is a selective, orally active, non-covalent inhibitor of PI3Kδ. Zandelisib can sustainably inhibit AKT phosphorylation and downstream signaling pathways. Zandelisib can be used in the study of malignancies such as relapsed/refractory B-cell lymphoma .
loading...
    loading...